(19)
(11) EP 1 240 197 A1

(12)

(43) Date of publication:
18.09.2002 Bulletin 2002/38

(21) Application number: 00980840.3

(22) Date of filing: 28.11.2000
(51) International Patent Classification (IPC)7C07K 14/545, C12N 15/52, C12N 15/63, C12N 5/10, C12N 15/74, C12N 15/79, C07K 16/24, C07K 16/46, A61K 38/19, C12N 5/16, C12N 15/62, C12Q 1/68, G01N 33/53, A61K 9/50, A01K 67/027
(86) International application number:
PCT/US0032/400
(87) International publication number:
WO 0104/2305 (14.06.2001 Gazette 2001/24)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 10.12.1999 US 170052 P

(71) Applicant: Amgen Inc.,
Thousand Oaks,California 91320-1799 (US)

(72) Inventors:
  • WELCHER, Andrew, A.
    Ventura, CA 93001 (US)
  • LUETHY, Roland
    Newbury Park, CA 91320 (US)
  • JING, Shuqian
    Thousand Oaks, CA 91362 (US)

(74) Representative: Grünecker, Kinkeldey, Stockmair & SchwanhäusserAnwaltssozietät 
Maximilianstrasse 58
80538 München
80538 München (DE)

   


(54) INTERLEUKIN-1 RECEPTOR ANTAGONIST-LIKE MOLECULES AND USES THEREOF